GLP-1 Receptor Agonists in Obese Patients with Inflammatory Bowel Disease: from Molecular Mechanisms to Clinical Considerations and Practical Recommendations for Safe and Effective Use
Konstantinos Arvanitakis, Theocharis Koufakis, Djordje S. Popovic, Giuseppe Maltese, Омар Мустафа, Michael Doumas, Όλγα Γιουλεμέ, Kalliopi Kotsa, Georgios Germanidis
Topics & Concepts
MedicineInflammatory bowel diseaseDiseaseLiraglutideDiabetes mellitusDysbiosisObesityBioinformaticsClinical trialGut floraType 2 diabetesIntensive care medicineImmunologyInternal medicineEndocrinologyBiologyInflammatory Bowel DiseaseGastrointestinal motility and disordersHelicobacter pylori-related gastroenterology studies